Share

Following on from the two articles published last week about treating Parkinson’s and Atherosclerosis by adjusting macrophage populations to facilitate healing, we have yet another study[1].

This time the focus of the research is on peripheral nerve injury, but again using the same approach of the two studies we previously reported on.

What is peripheral nerve injury?

The peripheral nerves are located outside of the brain and spinal cord. They carry signals to the muscles to initiate movement as well as transporting sensory information back from the extremities and other tissues to the spinal cord and brain.

When peripheral nerves are injured, they distort or interrupt the messages between the brain and the rest of the body and are a major source of disability. Peripheral nerve damage often results in painful neuropathies which can impair sensation, movement, gland or organ function and other aspects of health, depending on the type of nerve that is damaged.

Macrophages to the rescue

Macrophages are derived from monocytes, a type of immune cell which can change into one of a number macrophage types, depending on the local signalling environment when they arrive at an injury site. The macrophage types of interest here are the M1 and M2 cells.

In general, M1 macrophages produce pro-inflammatory signals and high levels of oxidative metabolites, and M2 macrophages make the environment supportive for tissue repair by producing anti-inflammatory signals that facilitate tissue regeneration.

As discussed in our previous article, adjusting the ratios of M1 and M2 type macrophages is the focus of the therapeutic approach here. By changing the populations of macrophages to favour the M2 type, the researchers here are seeking to repair nerve damage.

The researchers here demonstrate that injuries even in tissue types not normally repaired reliably, such as nerve tissue, can be encouraged to heal by altering the population of macrophages in the tissue.

Conclusion

There is now a good amount of supporting evidence showing that macrophages play a key role in tissue repair and regeneration[2]. Researchers have demonstrated in a number of studies that adjusting the ratio of macrophages to favour the M2 “healing” cell type can improve healing and outcomes and encourage regeneration that would not usually occur reliably in nerve tissues[3].

The study discussed today is another example of the direction researchers are heading, i.e. encouraging the body’s own repair systems to heal injuries when it would not normally do so.

If you enjoyed this article and would like to support us to create more articles, events, livestream panels, talks and scientific advocacy, please consider becoming a Lifespan Hero.

Literature

[1] Mokarram, N., Dymanus, K., Srinivasan, A., Lyon, J. G., Tipton, J., Chu, J., … & Bellamkonda, R. V. (2017). Immunoengineering nerve repair. Proceedings of the National Academy of Sciences, 201705757.

[2] Simkin, J., Gawriluk, T. R., Gensel, J. C., & Seifert, A. W. (2017). Macrophages are necessary for epimorphic regeneration in African spiny mice. elife, 6, e24623.

[3] Mokarram, N., Merchant, A., Mukhatyar, V., Patel, G., & Bellamkonda, R. V. (2012). Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials, 33(34), 8793-8801.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Write a comment:

*

Your email address will not be published.

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD